BioTechGrid

Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease

September 17, 2026

Credit: mi-viri / iStock / Getty Images Plus Diabetic kidney disease is one of the most common and serious complications…

Genetics

Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research

September 17, 2026

Credit: Tashi-Delek/Getty Images Molecular Devices and STEMCELL Technologies said they have a developed a validated automated workflow that can be…

Genetics

High-Grade Glioma Biology Varies by Age and Sex, Revealing Potential Treatment Targets

September 17, 2026

Credit: Dragana991/Getty Images Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified candidate treatment targets…

Genetics

Sartorius and NIBRT Partner on Intensified and Continuous Bioprocessing Training Center

September 17, 2026

Cell culture [dra_schwartz/Getty Images] Sartorius and the Ireland-based National Institute for Bioprocessing Research and Training (NIBRT) are partnering to establish…

Genetics

Mithrl Raises $20M to Expand Deployment of Its Biomedical World Model Across Biopharma

September 17, 2026

Credit: Yuichiro Chino / Moment / Getty Images Vivek Adarsh’s reasons for founding Mithrl are quite personal. About 15 years…

Biotechnology

Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol

September 17, 2026

A new biotech has sprung out of stealth with a bold vision to develop the “greatest therapeutic of all time”—a…

Research

DPHARM: How to address the clinical trial enrollment crisis?

September 17, 2026

Clinical trials are facing an enrollment crisis. Around 80% of trials don’t meet their enrollment timelines, and fewer than 5%…

Biotechnology

After one failed acquisition attempt, Lisata finds lifeline in Marea merger

September 17, 2026

After a failed merger that led to massive layoffs and a lawsuit, solid tumor biotech Lisata Therapeutics has found a…

Biotechnology

Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive

September 17, 2026

Roche is paying Dualitas Therapeutics $36.5 million upfront to screen over 300,000 novel bispecific combinations in search of new treatments…

Biotechnology

North Immunology goes public via reverse merger as eczema drug heads toward clinic

September 17, 2026

North Immunology has decided its path to taking an atopic dermatitis drug into the clinic involves going public via a…

Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease

Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research

High-Grade Glioma Biology Varies by Age and Sex, Revealing Potential Treatment Targets

Sartorius and NIBRT Partner on Intensified and Continuous Bioprocessing Training Center

Mithrl Raises $20M to Expand Deployment of Its Biomedical World Model Across Biopharma

Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease

Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research

High-Grade Glioma Biology Varies by Age and Sex, Revealing Potential Treatment Targets

Sartorius and NIBRT Partner on Intensified and Continuous Bioprocessing Training Center

Mithrl Raises $20M to Expand Deployment of Its Biomedical World Model Across Biopharma

Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol

DPHARM: How to address the clinical trial enrollment crisis?

After one failed acquisition attempt, Lisata finds lifeline in Marea merger

Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive

North Immunology goes public via reverse merger as eczema drug heads toward clinic

Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure

Newly formed Jaguar acquires Afib device assets from J&J

After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer

J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg